The Journal of nutritional biochemistry · 2026
Dietary Zeaxanthin Attenuates Cigarette Smoke-Induced COPD by Suppressing ERK-Driven Apoptosis.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Liu Ziyi, Liang Qinshi, Liu Yifan, Zheng Huiru, Zeng Huihui, Zhang Hongliang
Аннотация
BACKGROUND: Dietary zeaxanthin's role in COPD remains underexplored.
METHODS: A multi-dimensional approach integrating NHANES epidemiological data, multi-omics analyses (network pharmacology, transcriptomics, molecular docking), and experimental validation in a CSE-induced mouse model and HBE cells.
RESULTS: NHANES analysis revealed an inverse association between zeaxanthin intake and COPD risk. Multi-omics identified MAPK1 (ERK2) as a core target, with molecular docking predicting favorable zeaxanthin-MAPK1/MAPK3 interactions. Zeaxanthin alleviated emphysema, improved lung function, and reduced apoptosis/inflammation in vivo, and protected HBE cells in vitro. Mechanistically, it dose-dependently inhibited ERK phosphorylation and downstream cleaved caspase-3 activation. PMA-mediated reactivation of ERK partially reversed the anti-apoptotic effect of zeaxanthin.
CONCLUSION: Dietary zeaxanthin protects against COPD by suppressing the ERK-mediated apoptotic pathway, supporting its potential as a nutritional intervention.
METHODS: A multi-dimensional approach integrating NHANES epidemiological data, multi-omics analyses (network pharmacology, transcriptomics, molecular docking), and experimental validation in a CSE-induced mouse model and HBE cells.
RESULTS: NHANES analysis revealed an inverse association between zeaxanthin intake and COPD risk. Multi-omics identified MAPK1 (ERK2) as a core target, with molecular docking predicting favorable zeaxanthin-MAPK1/MAPK3 interactions. Zeaxanthin alleviated emphysema, improved lung function, and reduced apoptosis/inflammation in vivo, and protected HBE cells in vitro. Mechanistically, it dose-dependently inhibited ERK phosphorylation and downstream cleaved caspase-3 activation. PMA-mediated reactivation of ERK partially reversed the anti-apoptotic effect of zeaxanthin.
CONCLUSION: Dietary zeaxanthin protects against COPD by suppressing the ERK-mediated apoptotic pathway, supporting its potential as a nutritional intervention.